C-Peptide, 180 Minutes

Also known as: C PEP 180

Clinical Use

Use

The C-Peptide, 180 Minutes test is utilized to evaluate pancreatitis and to assist in the differentiation of pancreatic insulinomas from non-pancreatic causes of hypoglycemia. It aids in the assessment of beta cell function and helps in the management of individuals with diabetes to observe insulin production. This test can be particularly useful in determining residual beta cell function in patients with diabetes being treated with insulin.

Special Instructions

Not provided.

Limitations

The C-Peptide, 180 Minutes test has certain limitations. Reference ranges have not been established for this test, and the interpretation of results should be considered in the context of the patient's clinical presentation and other laboratory findings. Grossly hemolyzed specimens may be rejected and cannot be processed, impacting test results. Stability of the specimen may also affect test accuracy: specimens must be separated from cells within 2 hours of collection, and stability varies with storage conditions.

Test Details

FDA Approved

New York Approved

Methodology

Immunoassay (CLIA)

Biomarkers

C-Peptide

Analyte

C-Peptide

Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)

LOINC Codes

Result Codes

13043-5 - C peptide 3h p chal SerPl-mCnc

Result Turnaround Time

1 day

Specimen

Serum

Volume

Not provided

Minimum Volume

1 mL

Container

Serum Separator Tube (SST)

Collection Instructions

Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transport 1 mL serum to an ARUP Standard Transport Tube.